Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

CytomX Therapeutics (CTMX) Shares Issued: 2015-2025

Historic Shares Issued for CytomX Therapeutics (CTMX) over the last 7 years, with Jun 2025 value amounting to $93.4 million.

  • CytomX Therapeutics' Shares Issued rose 1899.85% to $93.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $100.3 million, marking a year-over-year increase of 190.55%. This contributed to the annual value of $6.9 million for FY2024, which is 76.74% down from last year.
  • As of Q2 2025, CytomX Therapeutics' Shares Issued stood at $93.4 million, which was up 4,439.28% from $2.1 million recorded in Q4 2024.
  • Over the past 5 years, CytomX Therapeutics' Shares Issued peaked at $107.7 million during Q1 2021, and registered a low of $7,000 during Q1 2022.
  • In the last 3 years, CytomX Therapeutics' Shares Issued had a median value of $3.4 million in 2024 and averaged $21.7 million.
  • As far as peak fluctuations go, CytomX Therapeutics' Shares Issued soared by 4,893.60% in 2021, and later tumbled by 99.99% in 2022.
  • Over the past 5 years, CytomX Therapeutics' Shares Issued (Quarterly) stood at $107.7 million in 2021, then plummeted by 99.99% to $190,000 in 2022, then fell by 29.71% to $29.4 million in 2023, then skyrocketed by 1,372.87% to $2.1 million in 2024, then soared by 1,899.85% to $93.4 million in 2025.
  • Its Shares Issued stands at $93.4 million for Q2 2025, versus $2.1 million for Q4 2024 and $4.7 million for Q2 2024.